Camptothecin analogs conjugated to a glutamine residue in a protein, and their use

NZ835068APending Publication Date: 2026-07-31REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835068
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-02-26
Filing Date
2021-07-12
Publication Date
2026-07-31

Smart Images

  • Figure 00000208_0000
    Figure 00000208_0000
  • Figure 00000251_0000
    Figure 00000251_0000
  • Figure 00000300_0000
    Figure 00000300_0000
Patent Text Reader

Abstract

Described herein are protein-drug conjugates and compositions thereof that are useful, for example, for target-specific delivery of therapeutic moieties, e.g., camptothecin analogs and / or derivatives. In certain embodiments, provided are specific and efficient methods for producing protein-drug constructs (e.g., antibody-drug conjugates) utilizing a combination of transglutaminase and 1,3-cycloaddition techniques. Camptothecin analogs, antibody-drug conjugates, and compositions which comprise glutaminyl-modified antibodies and camptothecin analog payloads and are provided.
Need to check novelty before this filing date? Find Prior Art